BrainsGate Ltd., a Caecarea, Israel-based developer of an electrical stimulation system that helps certain CNS disorders, has raised $27.5 million in Series C funding. Johnson & Johnson Development Corp. led the round, and was joined by VC-Fund Agate Medical Investments and return backers Elron Electronic Industries, Pitango Venture Capital, MB Venture Capital and Alice Lab.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
